Literature DB >> 21078675

Thr-370 is responsible for CDK11(p58) autophosphorylation, dimerization, and kinase activity.

Yayun Chi1, Chunyi Zhang, Hongliang Zong, Yi Hong, Xiangfei Kong, Haiou Liu, Weiying Zou, Yanlin Wang, Xiaojing Yun, Jianxin Gu.   

Abstract

CDK11(p58), a member of the p34(cdc2)-related kinase family, is associated with cell cycle progression, tumorigenesis, and proapoptotic signaling. It is also required for the maintenance of chromosome cohesion, the maturation of centrosome, the formation of bipolar spindle, and the completion of mitosis. Here we identified that CDK11(p58) interacted with itself to form homodimers in cells, whereas D224N, the kinase-dead mutant, failed to form homodimers. CDK11(p58) was autophosphorylated, and the main functions of CDK11(p58), such as kinase activity, transactivation of nuclear receptors, and proapoptotic signal transduction, were dependent on its autophosphorylation. Furthermore, the in vitro kinase assay indicated that CDK11(p58) was autophosphorylated at Thr-370. By mutagenesis, we created CDK11(p58) T370A and CDK11(p58) T370D, which mimic the dephosphorylated and phosphorylated forms of CDK11(p58), respectively. The T370A mutant could not form dimers and be phosphorylated by the wild type CDK11(p58) and finally lost the kinase activity. Further functional research revealed that T370A failed to repress the transactivation of androgen receptor and enhance the cell apoptosis. Overall, our data indicated that Thr-370 is responsible for the autophosphorylation, dimerization, and kinase activity of CDK11(p58). Moreover, Thr-370 mutants might affect CDK11(p58)-mediated signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21078675      PMCID: PMC3023469          DOI: 10.1074/jbc.M110.107367

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Identification and characterization of a novel cell cycle-regulated internal ribosome entry site.

Authors:  S Cornelis; Y Bruynooghe; G Denecker; S Van Huffel; S Tinton; R Beyaert
Journal:  Mol Cell       Date:  2000-04       Impact factor: 17.970

2.  PITSLRE p110 protein kinases associate with transcription complexes and affect their activity.

Authors:  Janeen H Trembley; Dongli Hu; Li-Chung Hsu; Cho-Yau Yeung; Clive Slaughter; Jill M Lahti; Vincent J Kidd
Journal:  J Biol Chem       Date:  2001-11-14       Impact factor: 5.157

3.  Interaction of p58(PITSLRE), a G2/M-specific protein kinase, with cyclin D3.

Authors:  Songwen Zhang; Mingmei Cai; Si Zhang; Songli Xu; She Chen; Xiaoning Chen; Chun Chen; Jianxin Gu
Journal:  J Biol Chem       Date:  2002-06-24       Impact factor: 5.157

4.  Different effects of p58PITSLRE on the apoptosis induced by etoposide, cycloheximide and serum-withdrawal in human hepatocarcinoma cells.

Authors:  Ming M Cai; Song W Zhang; Si Zhang; She Chen; Jun Yan; Xiao Y Zhu; Yun Hu; Chun Chen; Jian X Gu
Journal:  Mol Cell Biochem       Date:  2002-09       Impact factor: 3.396

Review 5.  Cyclin dependent kinase 11 in RNA transcription and splicing.

Authors:  Janeen H Trembley; Pascal Loyer; Dongli Hu; Tongyuan Li; Jose Grenet; Jill M Lahti; Vincent J Kidd
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2004

6.  Increased expression of a 58-kDa protein kinase leads to changes in the CHO cell cycle.

Authors:  B A Bunnell; L S Heath; D E Adams; J M Lahti; V J Kidd
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

7.  PITSLRE protein kinase activity is associated with apoptosis.

Authors:  J M Lahti; J Xiang; L S Heath; D Campana; V J Kidd
Journal:  Mol Cell Biol       Date:  1995-01       Impact factor: 4.272

8.  Cleavage of PITSLRE kinases by ICE/CASP-1 and CPP32/CASP-3 during apoptosis induced by tumor necrosis factor.

Authors:  R Beyaert; V J Kidd; S Cornelis; M Van de Craen; G Denecker; J M Lahti; R Gururajan; P Vandenabeele; W Fiers
Journal:  J Biol Chem       Date:  1997-05-02       Impact factor: 5.157

9.  CDK11 complexes promote pre-mRNA splicing.

Authors:  Dongli Hu; Akila Mayeda; Janeen H Trembley; Jill M Lahti; Vincent J Kidd
Journal:  J Biol Chem       Date:  2002-12-24       Impact factor: 5.157

10.  CDK11p58 phosphorylation of PAK1 Ser174 promotes DLC2 binding and roles on cell cycle progression.

Authors:  Xiangfei Kong; Huachen Gan; Yuqing Hao; Chunming Cheng; Jianhai Jiang; Yi Hong; Junwu Yang; Hao Zhu; Yayun Chi; Xiaojing Yun; Jianxin Gu
Journal:  J Biochem       Date:  2009-06-11       Impact factor: 3.387

View more
  11 in total

1.  Identification and characterization of the BmCyclin L1-BmCDK11A/B complex in relation to cell cycle regulation.

Authors:  Tai-Hang Liu; Yun-Fei Wu; Xiao-Long Dong; Cai-Xia Pan; Guo-Yu Du; Ji-Gui Yang; Wei Wang; Xi-Yan Bao; Peng Chen; Min-Hui Pan; Cheng Lu
Journal:  Cell Cycle       Date:  2017-03-20       Impact factor: 4.534

Review 2.  Androgen receptor phosphorylation: biological context and functional consequences.

Authors:  Yulia Koryakina; Huy Q Ta; Daniel Gioeli
Journal:  Endocr Relat Cancer       Date:  2014-01-14       Impact factor: 5.678

3.  CHK2 kinase promotes pre-mRNA splicing via phosphorylating CDK11(p110).

Authors:  H-H Choi; H-K Choi; S Y Jung; J Hyle; B-J Kim; K Yoon; E-J Cho; H-D Youn; J M Lahti; J Qin; S-T Kim
Journal:  Oncogene       Date:  2012-11-26       Impact factor: 9.867

4.  Androgen receptor function links human sexual dimorphism to DNA methylation.

Authors:  Ole Ammerpohl; Susanne Bens; Mahesh Appari; Ralf Werner; Bernhard Korn; Stenvert L S Drop; Frans Verheijen; Yvonne van der Zwan; Trevor Bunch; Ieuan Hughes; Martine Cools; Felix G Riepe; Olaf Hiort; Reiner Siebert; Paul-Martin Holterhus
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

5.  Critical role of CDK11(p58) in human breast cancer growth and angiogenesis.

Authors:  Yayun Chi; Sheng Huang; Haojie Peng; Mengying Liu; Jun Zhao; Zhiming Shao; Jiong Wu
Journal:  BMC Cancer       Date:  2015-10-15       Impact factor: 4.430

6.  Androgen receptor is a potential novel prognostic marker and oncogenic target in osteosarcoma with dependence on CDK11.

Authors:  Yunfei Liao; Slim Sassi; Stefan Halvorsen; Yong Feng; Jacson Shen; Yan Gao; Gregory Cote; Edwin Choy; David Harmon; Henry Mankin; Francis Hornicek; Zhenfeng Duan
Journal:  Sci Rep       Date:  2017-03-06       Impact factor: 4.379

7.  A cyclin-dependent kinase, CDK11/p58, represses cap-dependent translation during mitosis.

Authors:  Sihyeon An; Oh Sung Kwon; Jinbae Yu; Sung Key Jang
Journal:  Cell Mol Life Sci       Date:  2020-02-06       Impact factor: 9.261

Review 8.  Orphan kinases turn eccentric: a new class of cyclin Y-activated, membrane-targeted CDKs.

Authors:  Petra Mikolcevic; Johannes Rainer; Stephan Geley
Journal:  Cell Cycle       Date:  2012-08-16       Impact factor: 4.534

9.  CDK11p58 inhibits ERα-positive breast cancer invasion by targeting integrin β3 via the repression of ERα signaling.

Authors:  Yayun Chi; Sheng Huang; Lei Wang; Ruoji Zhou; Lisha Wang; Xiuying Xiao; Dali Li; Ying Cai; Xiaoyan Zhou; Jiong Wu
Journal:  BMC Cancer       Date:  2014-08-08       Impact factor: 4.430

10.  CAPG enhances breast cancer metastasis by competing with PRMT5 to modulate STC-1 transcription.

Authors:  Sheng Huang; Yayun Chi; Yi Qin; Ziliang Wang; Bingqiu Xiu; Yonghui Su; Rong Guo; Liang Guo; Hefen Sun; Chujia Zeng; Shuling Zhou; Xin Hu; Sheng Liu; Zhimin Shao; Zhaohui Wu; Wei Jin; Jiong Wu
Journal:  Theranostics       Date:  2018-04-03       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.